Delivery Order SPE2DR25D1017-SPE2DR26F9APN
- Not listed
- The Defense Logistics Agency awarded a $4,828.41 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL doses. This is a firm fixed-price, non-set-aside contract with a completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $7,163.82 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. This competitively awarded, non-set-aside contract is classified as a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $13,657.29 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL of pharmaceutical product. The contract is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order issued under a larger contract vehicle. This delivery order falls under...
- The Defense Logistics Agency awarded a $11,022.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL formulation, under a non-competitive, non-set-aside procurement. The order, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $4,852.12 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $7,249.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) CF Pen 40 mg/0.4 mL pharmaceutical supplies on December 3, 2025, with completion scheduled for December 4, 2025. This non-set-aside competitive award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA...
- The Defense Logistics Agency awarded a $36,425.77 delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40mg/4ml (2 units) under a firm fixed price contract. This delivery order, issued on October 27, 2025, with an ultimate completion date of November 24, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been selected to fulfill this medical supply...
- The Defense Logistics Agency awarded a $13,075.97 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens, 40 mg/0.4 mL dosage. This contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,082.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of HUMIRA (Adalimumab) prefilled pens at 40 mg/0.4 mL. This is a non-set-aside competitive award with an ultimate completion date of October 28, 2025, with performance to occur at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,959.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The contract will be performed at...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9APNDelivery Order
The Defense Logistics Agency awarded a $12,559.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) 40 mg/0.4 mL prefilled pens. This non-competitive delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a prime indefinite delivery contract valued at $999,999,999.00 through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. This delivery order for HUMIRA, a biologic immunosuppressive medication used to treat autoimmune conditions, reflects the contractor's established role in supplying specialized pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems. The non-set-aside competitive contracting approach demonstrates AmerisourceBergen's capability to meet federal procurement requirements for critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 11/30/25 |